SCHEMBL8484785

SCHEMBL8484785

C=CCN(C)C/C=C/COc1ccc2c(-c3ccc(Br)cc3)nccc2c1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LSS P48449 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8484786 1.00 LSS (0.71) LSS
SCHEMBL8484760 0.86 LSS (0.69) LSS
SCHEMBL8484754 0.86 LSS (0.69) LSS
SCHEMBL8760752 0.83 LSS (1.00) LSS
SCHEMBL8760802 0.81 LSS (0.89) LSS
SCHEMBL8760808 0.81 LSS (0.89) LSS
SCHEMBL9068091 0.81 LSS (1.00) LSS
SCHEMBL17358773 0.81 LSS (1.00) LSS
SCHEMBL8484719 0.80 LSS (0.73) LSS
SCHEMBL8484715 0.80 LSS (0.73) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0778271-A2 Aminoalkyl-substituted benzo-heterocyclic compounds F. HOFFMANN-LA ROCHE AG (CH) 1997-06-11 EP claimed
US-5856503-A ANTICHOLESTEROL AGENTS HOFFMANN-LA ROCHE INC. (US) 1999-01-05 US disclosed
EP-0778271-A2 Aminoalkyl-substituted benzo-heterocyclic compounds F. HOFFMANN-LA ROCHE AG (CH) 1997-06-11 EP disclosed